Abstract
In patients with cirrhosis and hepatitis C virus (HCV) it has been hard to define the benefit of sustained virologic response (SVR) on patients survival because of selection bias and other confounding factors in studies. To overcome this, researchers studied 796 patients with HCV-related cirrhosis treated with interferon-based antiviral therapy and compared them with age […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
